The comparison of the effect of eicosapentaenoic acid and docosahexaenoic acid on lipoprotein profile & tumor necrosis factor-a in patients with helicobacter pylori Infection

Gastrointestinal & Liver Disease Research Center (Firoozgar GILDRC)0 个研究点目标入组 105 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•positive helicobacter pylori test result; no history of pharmaceutical treatment for infection eradication; no gastric surgery; no history of peptic ulcer; no any disease that cause inflammation & increase of serum inflammatory markers level such as diabetes, CVD, respiratoryinflammations such as asthma,...; no consumption of any drug other than prescribed drugs during the study; no consumption of antibiotic or bismut during 2 months before the trial; no consumption of antioxidant supplements such as Se, Zn, beta-caroten,... at least 3 months before the trial; no consumption of omega-3 supplements at least 3 months before the trial; no smoking; BMI less than 30; age between 20-60 years old; leaning to cooperation
•Exclusion criteria: no leaning to continuing the cooperation; any change in type or dose of prescribed drugs; any change in daily diet or physical activity; consumption of any antioxidant supplement; consumption of less than 70% of supplements given to patients at the start of the study

发起方

Gastrointestinal & Liver Disease Research Center (Firoozgar GILDRC)